Certified by Founder Lodge
Tacalyx GmbH
Germany - Berlin, BE
START UP
1 Disclosed Funding Rounds $12,843,270
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Tacalyx develops the next generation of anti-Cancer therapeutics in indications with high medical need
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 30 ,2026 | Seed | $12,843,270 |
Boehringer Ingelheim
Kurma Partners
Thuja Capital
Creathor Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Neurosoft Bioelectronics | $7,500,000 | (May 22, 2026)
Century Health | $5,000,000 | (May 22, 2026)
CVRD Health | $5,000,000 | (May 22, 2026)
Oorja Bio | $30,000,000 | (May 22, 2026)
Findd.AI | $21,000,000 | (May 22, 2026)
